Specifications
Species Reactivity
Human; Rat; Pig; Bovine
Applications
Application Notes
ELISA, IB
ELISA: Binds immobilized human, rat, porcine, and bovine FIX and human FIXa.
Immunoblotting: Binds human FIX and light chain of human FIXa under reduced conditions.
Inhibition: Does not prolong plasma clot time in aPTT clotting assay.
Recommended working dilution: Approximately 1-5 μg/ml. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded
Target
Alternative Names
F9; coagulation factor IX; Christmas disease; Factor IX; FIX; hemophilia B; plasma thromboplastic component; F9 p22; FIX F9; factor 9; factor IX F9; serine protease; Christmas factor; plasma thromboplastin component; P19; PTC; HEMB; THPH8; MGC129641; MGC1
Product Background
Antigen Description
Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca(2+) ions, phospholipids, and factor VIIIa.
Pathway
Blood Clotting Cascade, organism-specific biosystem; Complement and Coagulation Cascades, organism-specific biosystem; Complement and coagulation cascades, organism-specific biosystem; Complement and coagulation cascades, conserved biosystem; Extrinsic Pathway, organism-specific biosystem; Formation of Fibrin Clot (Clotting Cascade), organism-specific biosystem; Gamma-carboxylation of protein precursors, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-1777 in a publication?
Let us know and earn a reward for your research.